Tuesday, July 27, 2010

Medicare Cut in Dialysis Fees May Slash Amgen Sales of Anemia Drug Epogen - Bloomberg

Anemia drugs “were a profit center, now they’ll be an expense,” Yee said in a July 23 telephone interview. “Now there will be some incentive to use the minimal amount.” The cost of anything more than the minimum would be borne by the dialysis providers, Yee said.

Posted via email from Jack's posterous

No comments: